Pliant Therapeutics PLRX Growth Metrics (2019-2026)

NASDAQ PLRX
$1.12 -0.05 (-4.27%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Sep2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
-0.13M-0.08M-0.12M0.07M-0.05M-0.07M-0.09M-1.85M
EBITDA Margin Growth (3y) (Quarter)
-0.32M-1.86M
EBITDA Margin (QoQ) (Quarter)
-0.04M0.05M-0.10M0.17M-0.16M0.03M-0.13M-1.59M
EBIT Margin Growth (1y) (Quarter)
-0.13M-0.08M-0.12M0.07M-0.05M-0.07M-0.09M-1.85M
EBIT Margin Growth (3y) (Quarter)
-0.32M-1.86M
EBIT Margin (QoQ) (Quarter)
-0.04M0.05M-0.10M0.17M-0.16M0.03M-0.13M-1.59M
EBT Margin Growth (1y) (Quarter)
-0.13M-0.07M-0.13M0.07M-0.06M-0.06M-0.08M-1.90M
EBT Margin Growth (3y) (Quarter)
-0.31M-1.90M
EBT Margin (QoQ) (Quarter)
-0.04M0.05M-0.12M0.18M-0.17M0.04M-0.13M-1.64M
Enterprise Value Growth (1y) (Quarter)
24.81%27.55%32.50%32.95%-62.97%-65.10%-223.82%-239.35%-45.35%-49.23%16.44%21.35%22.75%28.03%36.64%39.79%40.23%46.32%44.09%39.86%
Enterprise Value Growth (3y) (Quarter)
-47.71%-21.12%-21.21%-21.30%-22.24%-21.41%-22.32%-21.04%-19.68%-17.13%12.44%16.77%33.35%34.21%
Enterprise Value Growth (5y) (Quarter)
-28.19%3.40%3.83%7.16%8.34%8.31%
Enterprise Value (QoQ) (Quarter)
9.40%9.25%11.12%8.24%-120.20%8.07%-74.32%3.84%5.68%5.61%2.40%9.49%7.35%12.06%14.08%13.99%8.02%21.03%10.50%7.48%
FCF Margin Growth (1y) (Quarter)
-0.11M-0.05M-0.11M0.06M0.02M-0.07M-0.06M-0.98M
FCF Margin Growth (3y) (Quarter)
-0.22M-1.05M
FCF Margin (QoQ) (Quarter)
-0.03M0.05M-0.08M0.12M-0.07M-0.05M-0.06M-0.80M
Interest Coverage Ratio Growth (1y) (Quarter)
-62.73%109.95%-23.09%-29.42%60.85%79.68%-187.87%-0.10%-41.73%-530.98%22.74%52.91%52.99%69.01%29.55%98.39%50.95%83.46%99.21%
Interest Coverage Ratio Growth (3y) (Quarter)
1.99%7.39%-386.26%-169.79%3.35%8.32%-39.89%15.19%36.11%-63.87%-16.15%80.35%31.12%-30.47%83.72%
Interest Coverage Ratio Growth (5y) (Quarter)
15.00%11.95%-129.37%31.68%26.94%47.60%56.66%
Interest Coverage Ratio (QoQ) (Quarter)
-136.75%106.98%-348.48%-215.22%28.39%132.03%-498.10%-9.61%-1.39%2.59%28.63%33.20%-1.22%35.77%-62.20%98.47%-2,983.78%78.35%92.22%
Net Margin Growth (1y) (Quarter)
-0.13M-0.08M-0.12M0.07M-0.04M-0.06M-0.06M-1.60M
Net Margin Growth (3y) (Quarter)
-1.61M
Net Margin (QoQ) (Quarter)
-0.04M0.05M-0.10M0.17M-0.15M0.03M-0.10M-1.38M
Operating Margin Growth (1y) (Quarter)
-0.13M-0.08M-0.12M0.07M-0.05M-0.07M-0.09M-1.85M
Operating Margin Growth (3y) (Quarter)
-0.32M-1.86M
Operating Margin (QoQ) (Quarter)
-0.04M0.05M-0.10M0.17M-0.16M0.03M-0.13M-1.59M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets Growth (3y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.000.00M
Return on Assets Growth (5y) (Quarter)
-1.00-1.00-1.000.00M
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter)
-0.00M-0.00M-0.00M-0.00M-527.00885.000.00M0.00M0.00M42.00-869.00-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-783.00999.000.00M
Return on Capital Employed Growth (3y) (Quarter)
-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-776.00-0.00M-0.00M-0.00M-0.00M
Return on Capital Employed Growth (5y) (Quarter)
-0.01M-0.01M-0.00M-0.00M
Return on Capital Employed (QoQ) (Quarter)
-762.00-663.00-763.00-0.00M0.00M749.00614.00276.00-440.00-408.00-298.00-407.00-825.00-656.00-971.00-432.00409.00211.00811.00434.00
Return on Sales Growth (1y) (Quarter)
-13.00-7.00-13.007.00-6.00-6.00-8.00-190.00-26.00-109.00-827.00
Return on Sales Growth (3y) (Quarter)
-31.00-190.00-46.00-123.00-847.00
Return on Sales (QoQ) (Quarter)
-4.005.00-12.0018.00-17.004.00-13.00-164.00147.00-78.00-731.00